Disclosures for "Treatment Options for NMOSD in Children: Effectiveness and Safety of Subcutaneous Tocilizumab "
-
Dr. Duque Ramirez has nothing to disclose.
-
Dr. Dresser has nothing to disclose.
-
Dr. Abuaf has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
-
The institution of Dr. Javed has received research support from Genentech Roche .